MYC and Hodgkins lymphoma: MiR-24-3p is up-regulated in HL; it affects cell growth by targeting both cyclin dependent kinase inhibitor 1B (CDKN1B)/P27kip1 and MYC in HL cell lines; its inhibition increases the apoptotic cells [208].